News
Jan 22, 2024
A compound originally developed to treat cancer could be repurposed to treat polycystic kidney disease, an inherited condition that can lead to kidney failure.
Dec 12, 2023
Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine.
Nov 28, 2023
Using fluorescent labels that switch on and off, MIT engineers can study how molecules in a cell interact to control the cell’s behavior.
Nov 15, 2023
MIT professors Gene-Wei Li and Michael Birnbaum are among the 12 researchers named 2023 Innovation Fund investigators by The Pew Charitable Trusts.
Oct 10, 2023
Five MIT faculty, along with seven additional affiliates, are honored for outstanding contributions to medical research.
Sep 29, 2023
MIT spinout Kronos Bio, founded by Associate Professor Angela Koehler, studies the complex signaling networks of cancer cells to find new drug targets.
Aug 11, 2023
MIT engineers developed a new way to create these arrays, by scaffolding quantum rods onto patterned DNA.
Aug 3, 2023
In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.
Jul 6, 2023
BioAutoMATED, an open-source, automated machine-learning platform, aims to help democratize artificial intelligence for research labs.
Jul 5, 2023
The new strategy may enable engineered T cells to eradicate solid tumors such as glioblastoma.
- ‹ previous
- 2 of 59
- next ›